Anand Rathi Wealth Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: July 26, 2025, 1:50 pm

Competitors of Anand Rathi Wealth Ltd

All Competitor Stocks of Anand Rathi Wealth Ltd

Quarterly Result

Last Updated: July 16, 2025, 2:54 pm

Below is a detailed analysis of the quarterly data for Anand Rathi Wealth Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 265.00 Cr.. The value appears strong and on an upward trend. It has increased from 213.00 Cr. (Mar 2025) to 265.00 Cr., marking an increase of 52.00 Cr..
• For Expenses, as of Jun 2025, the value is 139.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 125.00 Cr. (Mar 2025) to 139.00 Cr., marking an increase of 14.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 125.00 Cr.. The value appears strong and on an upward trend. It has increased from 89.00 Cr. (Mar 2025) to 125.00 Cr., marking an increase of 36.00 Cr..
• For OPM %, as of Jun 2025, the value is 47.00%. The value appears strong and on an upward trend. It has increased from 42.00% (Mar 2025) to 47.00%, marking an increase of 5.00%.
• For Other Income, as of Jun 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 18.00 Cr. (Mar 2025) to 9.00 Cr., marking a decrease of 9.00 Cr..
• For Interest, as of Jun 2025, the value is 4.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 4.00 Cr..
• For Depreciation, as of Jun 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 6.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 124.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2025) to 124.00 Cr., marking an increase of 26.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 26.00%.
• For Net Profit, as of Jun 2025, the value is 92.00 Cr.. The value appears strong and on an upward trend. It has increased from 72.00 Cr. (Mar 2025) to 92.00 Cr., marking an increase of 20.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 11.11. The value appears strong and on an upward trend. It has increased from 8.72 (Mar 2025) to 11.11, marking an increase of 2.39.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 22, 2025, 2:34 pm

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:54 pm

Below is a detailed analysis of the balance sheet data for Anand Rathi Wealth Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 42.00 Cr.. The value appears strong and on an upward trend. It has increased from 21.00 Cr. (Mar 2024) to 42.00 Cr., marking an increase of 21.00 Cr..
• For Reserves, as of Mar 2025, the value is 661.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 661.00 Cr..
• For Borrowings, as of Mar 2025, the value is 79.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 51.00 Cr. (Mar 2024) to 79.00 Cr., marking an increase of 28.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 187.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 160.00 Cr. (Mar 2024) to 187.00 Cr., marking an increase of 27.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 969.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 894.00 Cr. (Mar 2024) to 969.00 Cr., marking an increase of 75.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 172.00 Cr.. The value appears strong and on an upward trend. It has increased from 131.00 Cr. (Mar 2024) to 172.00 Cr., marking an increase of 41.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to 0.00 Cr., marking a decrease of 1.00 Cr..
• For Investments, as of Mar 2025, the value is 320.00 Cr.. The value appears strong and on an upward trend. It has increased from 202.00 Cr. (Mar 2024) to 320.00 Cr., marking an increase of 118.00 Cr..
• For Other Assets, as of Mar 2025, the value is 477.00 Cr.. The value appears to be declining and may need further review. It has decreased from 559.00 Cr. (Mar 2024) to 477.00 Cr., marking a decrease of 82.00 Cr..
• For Total Assets, as of Mar 2025, the value is 969.00 Cr.. The value appears strong and on an upward trend. It has increased from 894.00 Cr. (Mar 2024) to 969.00 Cr., marking an increase of 75.00 Cr..

Notably, the Reserves (661.00 Cr.) exceed the Borrowings (79.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Anand Rathi Wealth Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 5.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 36.17. This value is within the healthy range. It has decreased from 54.10 (Mar 24) to 36.17, marking a decrease of 17.93.
• For Diluted EPS (Rs.), as of Mar 25, the value is 36.17. This value is within the healthy range. It has decreased from 54.03 (Mar 24) to 36.17, marking a decrease of 17.86.
• For Cash EPS (Rs.), as of Mar 25, the value is 39.30. This value is within the healthy range. It has decreased from 58.62 (Mar 24) to 39.30, marking a decrease of 19.32.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.18. It has decreased from 158.16 (Mar 24) to 81.18, marking a decrease of 76.98.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 81.18. It has decreased from 158.16 (Mar 24) to 81.18, marking a decrease of 76.98.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 113.12. It has decreased from 173.17 (Mar 24) to 113.12, marking a decrease of 60.05.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 53.22. This value is within the healthy range. It has decreased from 79.24 (Mar 24) to 53.22, marking a decrease of 26.02.
• For PBIT / Share (Rs.), as of Mar 25, the value is 50.15. This value is within the healthy range. It has decreased from 74.61 (Mar 24) to 50.15, marking a decrease of 24.46.
• For PBT / Share (Rs.), as of Mar 25, the value is 48.76. This value is within the healthy range. It has decreased from 73.06 (Mar 24) to 48.76, marking a decrease of 24.30.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 36.23. This value is within the healthy range. It has decreased from 53.99 (Mar 24) to 36.23, marking a decrease of 17.76.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 36.11. This value is within the healthy range. It has decreased from 53.78 (Mar 24) to 36.11, marking a decrease of 17.67.
• For PBDIT Margin (%), as of Mar 25, the value is 47.04. This value is within the healthy range. It has increased from 45.75 (Mar 24) to 47.04, marking an increase of 1.29.
• For PBIT Margin (%), as of Mar 25, the value is 44.33. This value exceeds the healthy maximum of 20. It has increased from 43.08 (Mar 24) to 44.33, marking an increase of 1.25.
• For PBT Margin (%), as of Mar 25, the value is 43.10. This value is within the healthy range. It has increased from 42.19 (Mar 24) to 43.10, marking an increase of 0.91.
• For Net Profit Margin (%), as of Mar 25, the value is 32.02. This value exceeds the healthy maximum of 10. It has increased from 31.17 (Mar 24) to 32.02, marking an increase of 0.85.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 31.92. This value exceeds the healthy maximum of 20. It has increased from 31.05 (Mar 24) to 31.92, marking an increase of 0.87.
• For Return on Networth / Equity (%), as of Mar 25, the value is 44.48. This value is within the healthy range. It has increased from 34.67 (Mar 24) to 44.48, marking an increase of 9.81.
• For Return on Capital Employeed (%), as of Mar 25, the value is 54.39. This value is within the healthy range. It has increased from 44.38 (Mar 24) to 54.39, marking an increase of 10.01.
• For Return On Assets (%), as of Mar 25, the value is 31.18. This value is within the healthy range. It has increased from 25.57 (Mar 24) to 31.18, marking an increase of 5.61.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.02. This value is below the healthy minimum of 0.2. It has increased from 0.00 (Mar 24) to 0.02, marking an increase of 0.02.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has increased from 0.01 (Mar 24) to 0.03, marking an increase of 0.02.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has increased from 0.96 (Mar 24) to 1.02, marking an increase of 0.06.
• For Current Ratio (X), as of Mar 25, the value is 2.67. This value is within the healthy range. It has decreased from 3.45 (Mar 24) to 2.67, marking a decrease of 0.78.
• For Quick Ratio (X), as of Mar 25, the value is 2.67. This value exceeds the healthy maximum of 2. It has decreased from 3.45 (Mar 24) to 2.67, marking a decrease of 0.78.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 22.24 (Mar 24) to 0.00, marking a decrease of 22.24.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 20.48 (Mar 24) to 0.00, marking a decrease of 20.48.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 77.76 (Mar 24) to 0.00, marking a decrease of 77.76.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 79.52 (Mar 24) to 0.00, marking a decrease of 79.52.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 38.28. This value is within the healthy range. It has decreased from 51.25 (Mar 24) to 38.28, marking a decrease of 12.97.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 27.06. This value is within the healthy range. It has decreased from 35.92 (Mar 24) to 27.06, marking a decrease of 8.86.
• For Enterprise Value (Cr.), as of Mar 25, the value is 15,871.20. It has increased from 15,428.74 (Mar 24) to 15,871.20, marking an increase of 442.46.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 16.90. This value exceeds the healthy maximum of 3. It has decreased from 21.30 (Mar 24) to 16.90, marking a decrease of 4.40.
• For EV / EBITDA (X), as of Mar 25, the value is 35.92. This value exceeds the healthy maximum of 15. It has decreased from 46.55 (Mar 24) to 35.92, marking a decrease of 10.63.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 16.91. This value exceeds the healthy maximum of 3. It has decreased from 21.32 (Mar 24) to 16.91, marking a decrease of 4.41.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 77.75 (Mar 24) to 0.00, marking a decrease of 77.75.
• For Price / BV (X), as of Mar 25, the value is 23.56. This value exceeds the healthy maximum of 3. It has decreased from 23.80 (Mar 24) to 23.56, marking a decrease of 0.24.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 16.91. This value exceeds the healthy maximum of 3. It has decreased from 21.32 (Mar 24) to 16.91, marking a decrease of 4.41.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness